Zhu, Y., Tang, J., Li, X., Qin, T., & Wei, Y. (2020). Durable Response to Osimertinib in a Chinese Patient with Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation. Onco Targets Ther.
Citação norma ChicagoZhu, Yajie, Jianning Tang, Xin Li, Tian Qin, and Yang Wei. "Durable Response to Osimertinib in a Chinese Patient With Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation." Onco Targets Ther 2020.
Citação norma MLAZhu, Yajie, et al. "Durable Response to Osimertinib in a Chinese Patient With Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation." Onco Targets Ther 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.